Versant Capital Management, Inc Ardelyx, Inc. Transaction History
Versant Capital Management, Inc
- $710 Million
- Q3 2025
A detailed history of Versant Capital Management, Inc transactions in Ardelyx, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 27 shares of ARDX stock, worth $162. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27Holding current value
$162% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARDX
# of Institutions
230Shares Held
167MCall Options Held
517KPut Options Held
1.61M-
Black Rock Inc. New York, NY17.6MShares$106 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$96.5 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X015.1MShares$90.6 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny11.7MShares$70.2 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C311.5MShares$69 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $931M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...